East Windsor, NJ - The FDA has given i-STAT Corporation clearance to market its prothrombin time (PT) test for use with the company's portable clinical analyzer according to a company press release.

Thirteen patients with liver disease and an abnormal prothrombin time refractory to vitamin K therapy were studied (Tables 1 and 2). None of the patients were actively bleeding, and none had received ...

Recently, another modified one-stage method, developed by Owren, 7 has been given the distinctive name of thrombotest. Claims have been made that this test is more satisfactory for controlling ...

This page lists all known medications that could potentially lead to 'Prothrombin time ratio' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Do patients with renal disease have inherent coagulopathy? What prothrombin time (PT)/partial thromboplastin time (PTT) values can be expected with end-stage renal disease (ESRD)? —OMEL FIGUEROA, PA-C ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

This page lists all known medications that could potentially lead to 'Shortened Prothrombin Time' as a side effect. It's important to note that mild side effects are quite common with medications. The ...